International market

Recent Articles

RELATED ARTICLES

  1. The Chinese pharmaceutical firm has suffered its second clinical setback in a matter of weeks, after its U.S. partner halted trials of a sarcoma drug.
    Clinical trials come up short again for Alphamab Oncology
    9966.HK
  2. Akeso marks profit milestone with swift rights issue
    9926.HK
  3. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva